February 22, 2018 11 AM EST
Get insight into the study and understand the issues to avoid. Learn about the nuances uncovered and how to solve them. Grasp the key requirements not to overlook. Ensure your Barcodes meet the regulation.
Last year, GS1 US worked with two of the largest wholesale distributors in the United States to perform an exhaustive analysis of the barcodes received from drug manufacturers in their U.S. distribution centers.
In the study, GS1 scanned thousands of barcodes on products in their respective DC inventories and evaluated their conformance with GS1 US Drug Supply Chain Security Act (DSCSA) guidance.
Unfortunately, many problems were found. The results of this important study raise concerns about industry readiness for the DSCSA November 2018 serialization deadline and beyond—not so much about the percentage of manufacturers or products that will be serialized, but about the quality and usability of the serial numbers that will be present on drug packages.
The study found that only 6.6% of the products inspected were in compliance.
The final report of this study was recently published by GS1 US In this webinar, Peter Sturtevant, Sr. Director, Industry Engagement – Pharmaceuticals, at GS1 US, the key coordinator of the study, will explain the study and the issues it uncovered. Joe Lipari, Director of Cloud Based Implementation Services, and Dirk Rodgers, Global Regulatory Strategist, both with Systech International, will join in the discussion of these issues and present the things companies can do to avoid them and ensure their products will meet the regulation, and be acceptable by the wholesale distributors in 2019 and in 2023.
Meeting the EU Falsified Medicines Directive and Systech Quarterly Regulatory Update
A Closer Look at the Russian Pharma Serialization Pilot, and Systech Regulatory Update
The Clock is Ticking: Overcoming the Challenges of Implementing Serialization in the EU